Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorMuttamba, Winters
dc.contributor.authorTumwebaze, Racheal
dc.contributor.authorMugenyi, Levicatus
dc.contributor.authorBatte, Charles
dc.contributor.authorSekibira, Rogers
dc.contributor.authorNkolo, Abel
dc.contributor.authorKatamba, Achilles
dc.contributor.authorKasasa, Simon
dc.contributor.authorMajwala, Robert Kaos
dc.contributor.authorTuryahabwe, Stavia
dc.contributor.authorMugabe, Frank
dc.contributor.authorMugagga, Kaggwa
dc.contributor.authorLochoro, Peter
dc.contributor.authorDejene, Seyoum
dc.contributor.authorBirabwa, Estella
dc.contributor.authorMarra, Claudio
dc.contributor.authorBaena, Ines Garcia
dc.contributor.authorKirenga, Bruce
dc.date.accessioned2021-03-11T12:30:08Z
dc.date.available2021-03-11T12:30:08Z
dc.date.issued2020-09-16
dc.identifier273005204
dc.identifiera28fb17d-5cfe-406b-a481-09d21dcf32a7
dc.identifier32938411
dc.identifier85091129592
dc.identifier.citationMuttamba , W , Tumwebaze , R , Mugenyi , L , Batte , C , Sekibira , R , Nkolo , A , Katamba , A , Kasasa , S , Majwala , R K , Turyahabwe , S , Mugabe , F , Mugagga , K , Lochoro , P , Dejene , S , Birabwa , E , Marra , C , Baena , I G & Kirenga , B 2020 , ' Households experiencing catastrophic costs due to tuberculosis in Uganda : magnitude and cost drivers ' , BMC Public Health , vol. 20 , 1409 . https://doi.org/10.1186/s12889-020-09524-5en
dc.identifier.issn1471-2458
dc.identifier.otherPubMedCentral: PMC7493412
dc.identifier.otherORCID: /0000-0001-7154-2964/work/89628352
dc.identifier.urihttps://hdl.handle.net/10023/21611
dc.descriptionFunding: This survey was funded by CDC (grant number 3U2GGH001180-03S1) toWHO, a USAID Uganda WHO Grant (PIO grant AID-617-10-17-00001) and alsofunding from Doctors with Africa, CUAMM.en
dc.description.abstractBackground: Tuberculosis (TB) patients in Uganda incur large costs related to the illness, and while seeking and receiving health care. Such costs create access and adherence barriers which affect health outcomes and increase transmission of disease. The study ascertained the proportion of Ugandan TB affected households incurring catastrophic costs and the main cost drivers. Methods: A cross-sectional survey with retrospective data collection and projections was conducted in 2017. A total of 1178 drug resistant (DR) TB (44) and drug sensitive (DS) TB patients (1134), 2 weeks into intensive or continuation phase of treatment were consecutively enrolled across 67 randomly selected TB treatment facilities. Results: Of the 1178 respondents, 62.7% were male, 44.7% were aged 15-34 years and 55.5% were HIV positive. For each TB episode, patients on average incurred costs of USD 396 for a DS-TB episode and USD 3722 for a Multi drug resistant tuberculosis (MDR TB) episode. Up to 48.5% of households borrowed, used savings or sold assets to defray these costs. More than half (53.1%) of TB affected households experienced TB-related costs above 20% of their annual household expenditure, with the main cost drivers being non-medical expenditure such as travel, nutritional supplements and food. Conclusion: Despite free health care in public health facilities, over half of Ugandan TB affected households experience catastrophic costs. Roll out of social protection interventions like TB assistance programs, insurance schemes, and enforcement of legislation related to social protection through multi-sectoral action plans with central NTP involvement would palliate these costs.
dc.format.extent10
dc.format.extent747829
dc.language.isoeng
dc.relation.ispartofBMC Public Healthen
dc.subjectCatastrophic costsen
dc.subjectDissavingen
dc.subjectDirect medical costsen
dc.subjectIndirect non-medical costsen
dc.subjectHV Social pathology. Social and public welfareen
dc.subjectRA0421 Public health. Hygiene. Preventive Medicineen
dc.subjectNDASen
dc.subjectSDG 1 - No Povertyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccHVen
dc.subject.lccRA0421en
dc.titleHouseholds experiencing catastrophic costs due to tuberculosis in Uganda : magnitude and cost driversen
dc.typeJournal articleen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Infection and Global Health Divisionen
dc.identifier.doi10.1186/s12889-020-09524-5
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record